Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Research Excellence Framework (REF) is the UK’s system for assessing the quality of research in UK higher education institutions. It first took place in 2014. The next exercise will be conducted in 2021.

Preparations are underway for REF2021.  Paul Harrison from Psychiatry has been chosen to lead our submission for Unit of Assessment 4 Psychology Psychiatry and Neuroscience.  Paul successfully led our submission for REF2014 when Oxford was ranked top in the UK on the overall quality of our submission, and had the highest proportion of world leading research. We scored 100% for the quality of our research and training environment. 95% of our submission was rated as world leading or internationally excellent.  That was an outstanding performance.

Some of our Neuroscience research is returned under Unit of Assessment 5 Biological Sciences which was also highly commended under REF2014. For REF2021 Unit of Assessment 5 will be led by Francis Barr from the Department of Biochemistry. 

Research Impact plays an important part of our assessment.  The Neuroscience, Psychology and Psychiatry Impact Team is currently being chaired by Charles Vincent while David Clark is on sabbatical.

Similar stories

New WA Handley Chair of Psychiatry Appointed

Strategic Developments

Professor John Geddes has been appointed to the WA Handley Professorship of Psychiatry and will take up this post in November 2021.

Investigating New Treatment for Schizophrenia

Research Highlights Strategic Developments

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim has been announced to investigate a new drug target for the treatment of schizophrenia.

Retirement of Professor Peter Brown

Strategic Developments

This month sees the retirement of Professor Peter Brown as Director of the Medical Research Council Brain Network Dynamics Unit at the University of Oxford.

The ALBA Declaration

Strategic Developments

Improving Equality, Diversity and Inclusiveness.

Recognition of Distinction Awards 2020

Awards and Honours Strategic Developments

It is a great pleasure to announce that a number of Neuroscience researchers have been successful in the recent assessment process for the conferment of the title of full Professor.

Ambitious Oxford initiative launched to address graduate under-representation

Strategic Developments

Oxford University and its colleges have announced a major new scholarship scheme for black graduate students as part of a programme to transform its graduate population by creating more funding opportunities for under-represented groups.